ArticleFrontiers in psychiatry2026
An interpretable TimeMIL framework for fNIRS: differential diagnosis between schizophrenia and bipolar disorder.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Schizophrenia (SCZ) and bipolar disorder (BD) exhibit substantial overlap in clinical symptoms, making differential diagnosis a persistent challenge and leading to a high risk of misdiagnosis. Recently, functional near-infrared spectroscopy (fNIRS) during the verbal fluency task (VFT) has provided more objective neurofunctional markers for distinguishing between the two disorders than traditional behavioral scales. However, most existing studies have predominantly relied on conventional, hand-crafted feature analyses. A significant limitation of this approach is the scarcity of deep learning models tailored for high-dimensional fNIRS time-series data, coupled with a lack of methods for their interpretation. Methods: In this study, a time-aware multiple instance learning model (TimeMIL) was applied to fNIRS data (healthy controls [HC]: 52 participants, SCZ: 50 participants, BD: 67 participants) collected during VFT. This model captures global dependencies in multivariate, high-dimensional time series of fNIRS, which represents each fNIRS recording as a bag and automatically locates informative temporal segments via a learnable wavelet encoder and self-attention. Furthermore, an interpretability framework integrating GradientSHAP and Integrated Gradients was proposed to quantify segment-and region-level attributions. Model performance was evaluated using 5×5-fold cross-validation and an independent test set. Results: TimeMIL achieved 0.928 ± 0.016 accuracy and a macro-averaged AUC of 0.984 ± 0.007 for three-class classification, significantly outperforming other representative models, including one-dimensional convolutional neural networks (1D-CNNs), Transformers, and temporal convolutional networks (TCNs). Attribution analyses highlighted robust differences in the orbitofrontal cortex (OFC) across HC, SCZ, and BD, suggesting its potential as a candidate discriminative feature. The frontal pole cortex (FPC) and ventrolateral prefrontal cortex (VLPFC) exhibited SCZ-specific attribution patterns. Conclusion: This study represents the first application of TimeMIL to fNIRS-based psychiatric disease classification, accompanied by a dedicated interpretability framework that illuminates prefrontal dysfunction. By integrating high accuracy, robustness, and interpretability, the proposed interpretable TimeMIL framework facilitates development of objective, neuroimaging-based tools for early screening and differential diagnosis of major psychiatric disorders, pending further validation in clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.